Kevin Kotler’s Broadfin Capital’s and MELA Sciences (MELA)

A new filing with the SEC revealed, Kevin Kotler and his hedge fund Broadfin Capital revealed a trimmed stake in MELA Sciences, Inc (NASDAQ:MELA). In MELA Sciences, Kevin Kotler currently owns a total of 9.1 million shares, which make the stake equal to 9.99% of the common stock. The fund disclosed a position in the company at the beginning of last month reporting stake of 16.09% of the company’s common stock.

 Kevin Kotler

In its 8-K filing with the SEC, MELA Sciences revealed to have terminated an agreement signed with Broadfin Capital on January 31, 2014. The agreement granted Broadfin Capital the right to delegate one director to the Board of the company, as long as it held 30% of the company’s investment in the Preferred Stock or held the warrants.

MELA Sciences, Inc, designs, develops and commercializes non-invasive medical devices to provide information for dermatologists dealing with melanoma skin examinations. For the fourth quarter 2013, the company recorded an increase of 14.8% on the year in revenues to $140,000. For the year 2013, the company recorded $536,000 in revenues, an increase of 92.8% year on.

In February, it completed a private placement of $11.54 million, with two major healthcare institutional investors and its directors. The company sold non-redeemable preferred stock, which, if exercised, would result in net proceeds of approximately $9.8 million. Additionally, it also sold around 200,000 shares of its common stock to its directors.

Last month, MELA Sciences appointed Samuel Navarro, a medical device investment banker, as Director, bringing the Board to eight members. Prior to this, Mr. Navarro was Managing Director of Cowen & Co. in New York City and head of their Medical Technology Investment Banking initiatives.

One of the largest stockholders of MELA Sciences is Hal Mintz’s Sabby Capital, which held 4.3 million shares at the end of the fourth quarter of 2013. It is followed by billionaire Ken Griffin’s Citadel Investment Group, with approximately 18,400 shares.

Broadfin Capital is located in New York City. The fund has an equity portfolio of $758.2 million, concentrated in the Healthcare sector. Kevin Kotler, the founder of the fund has worked with The Galleon Group, ABN AMRO, and ING Barings.

Broadfin Capital has been active in the recent couple of months, reporting new stakes. Last month, the fund initiated position in Pernix Therapeutics (NASDAQ:PTX), with 3.5 million shares. In January, the fund disclosed holding a 6.9% stake in Retrophin Inc (NASDAQ:RTRX), which contains 1.61 million shares.

According to the fund’s latest 13F, top holdings of Broadfin Capital, as at the end of last year, were Depomed Inc (NASDAQ:DEPO), with a stake valued in excess of $50.2 million, followed by Lannett Company, Inc. (NYSE:LCI), of which it held around 1.3 million shares worth $44.4 million, and Angiodynamics Inc (NASDAQ:ANGO), in which it owned 2.5 million shares valued at more than $42.8 million.

Disclosure: none

Recommended Reading:

Kevin Kotler’s Broadfin Capital Initiates Stake in Eleven Biotherapeutics (EBIO) Following Its IPO

Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)

Kevin Kotler, Broadfin Capital Raise Holding in Derma Sciences Inc (DSCI)

 

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!